Disseminated fusariosis presenting as panniculitis-like lesions on the legs of a neutropenic girl with acute lymphoblastic leukemia

Dermatology Online Journal

Volumn 15, Issue 10, 2009, Pages

  Zhang, Cathryn Z ^a   Fung, Maxwell A ^b   Eisen, Daniel B ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ASPARAGINASE; CYTARABINE; DAUNORUBICIN; METHOTREXATE; PREDNISONE; VINCRISTINE; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIFUNGAL RESISTANCE; ARTICLE; BLOOD SAMPLING; CASE REPORT; CHILD; DIFFERENTIAL DIAGNOSIS; DRUG ERUPTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FUSARIOSIS; FUSARIUM; HUMAN; HUMAN TISSUE; ONYCHOMYCOSIS; PANNICULITIS; PUNCH BIOPSY; SCHOOL CHILD; SKIN DEFECT; SKIN EXAMINATION; DERMATOMYCOSIS; NEUTROPENIA;

CHILD; DERMATOMYCOSES; FEMALE; FUSARIUM; HUMANS; NEUTROPENIA; PANNICULITIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 71549143814     PISSN: None     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Dale, D.C., J. Crawford, and G. Lyman, Chemotherapy-Induced Neutropenia and Associated Complications in Randomized Clinical Trials: An Evidence-Based Review [abstract 1638]. Proc Am Soc Clin Oncol, 2001. 20(410a).
2. Lionakis, M.S. and D.P. Kontoyiannis, Fusarium infections in critically ill patients. Semin Respir Crit Care Med, 2004. 25(2): p. 159-169 [PubMed]
3. Nucci, M. and E. Anaissie, Fusarium infections in immunocompromised patients. Clin Microbiol Rev, 2007. 20(4): p. 695-704. [PubMed]
4. Bodey, G.P., et al., Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med, 1966. 64(2): p. 328-340 [PubMed]
5. Crawford, J., D.C. Dale, and G.H. Lyman, Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer, 2004. 100(2): p. 228-237 [PubMed]
6. Bodey, G.P., Dermatologic manifestations of infections in neutropenic patients. Infect Dis Clin North Am, 1994. 8(3): p. 655-675 [PubMed]
7. Ellis, M., Febrile neutropenia. Ann N Y Acad Sci, 2008. 1138: p. 329-350 [PubMed]
8. Mays, S.R. and P.R. Cohen, Emerging dermatologic issues in the oncology patient. Semin Cutan Med Surg, 2006. 25(4): p. 179-189 [PubMed]
9. Guhl, G. and A. Garcia-Diez, Subcutaneous sweet syndrome. Dermatol Clin, 2008. 26(4): p. 541-551, viii-ix. [PubMed]
10. Hayden, R.T., et al., In situ hybridization for the differentiation of Aspergillus, Fusarium, and Pseudallescheria species in tissue section. Diagn Mol Pathol, 2003. 12(1): p. 21-26 [PubMed]
11. Anaissie, E.J., et al., Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. Clin Infect Dis, 2001. 33(11): p. 1871-1878 [PubMed]
12. Boutati, E.I. and E.J. Anaissie, Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood, 1997. 90(3): p. 999-1008. [PubMed]
13. Nucci, M., et al., Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer, 2003. 98(2): p. 315-319 [PubMed]
14. Bodey, G.P., et al., Skin lesions associated with Fusarium infection. J Am Acad Dermatol, 2002. 47(5): p. 659-666 [PubMed]
15. Healy, M., et al., Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates. J Clin Microbiol, 2005. 43(10): p. 5278-5280 [PubMed] (Pubitemid 41484038)
16. Hue, F.X., et al., Specific detection of fusarium species in blood and tissues by a PCR technique. J Clin Microbiol, 1999. 37(8): p. 2434-2438 [PubMed]
17. Walsh, T.J., et al., Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. Antimicrob Agents Chemother, 2001. 45(12): p. 3487-3496 [PubMed]
18. Consigny, S., et al., Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient. Clin Infect Dis, 2003. 37(2): p. 311-313 [PubMed]
19. Ho, D.Y., et al., Treating disseminated fusariosis: amphotericin B, voriconazole or both? Mycoses, 2007. 50(3): p. 227-231 [PubMed]
20. Walsh, T.J., et al., Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J, 2002. 21(3): p. 240-248 [PubMed]
21. Perfect, J.R., et al., Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis, 2003. 36 (9): p. 1122-1131 [PubMed]
22. Hughes, W.T., et al., 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis, 2002. 34(6): p. 730-751 [PubMed]
23. Goldberg, E., et al., Empirical antifungal therapy for patients with neutropenia and persistent fever: Systematic review and meta-analysis. Eur J Cancer, 2008. 44(15): p. 2192-2203 [PubMed]